Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,486 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 101–132 of 132 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03026803	A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer	terminated	Phase 2	4	City of Hope Medical CenterOTHER	1	Apr 13, 2017	clinicaltrials
NCT00576056	Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC	terminated	Phase 2	19	University of PittsburghOTHER	1	Feb 15, 2017	clinicaltrials